Cite

HARVARD Citation

    André, F. et al. (n.d.). LBA3_PRAlpelisib (ALP) + fulvestrant (FUL) for advanced breast cancer (ABC): Results of the phase III SOLAR-1 trial. Annals of oncology. p. . [Online]. 
  
Back to record